Neurava logo — Innovative diagnostics technology for managing epilepsy and...

Neurava

Innovative diagnostics technology for managing epilepsy and reducing SUDEP risk.

Founded 2019 2-10 employees Seed Total: $4.23M Health Care, Medical Devices

General Information

Company Name Neurava
Founded Year 2019
Employees 2-10
Industries Health Care, Medical Devices
Funding Stage Seed
Social

Get notified when Neurava moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Neurava

Neurava, **founded in 2019**, is an innovative player in the Health Care industry, with a focus on developing **wearable diagnostics for epilepsy patients** and those at risk of SUDEP (sudden unexpected death in epilepsy). The company's **slogan**, "Innovative diagnostics technology for managing epilepsy and reducing SUDEP risk," encapsulates its core mission. Neurava's expertise lies in **medical device manufacturing, healthcare, and health diagnostics**. In its latest funding round in **April 3, 2024**, the company secured an impressive **$2.26M** from a diverse group of investors including **Elevate Ventures, Life Science Angels, First Leaf Capital, Purdue Innovates Incubator, Rivermount Ventures, and Union Chimique Belge**. This significant investment signals confidence from multiple reputable investors in Neurava's promising diagnostic solutions, positioning the company for further growth and impact in the healthcare space.

Taxonomy: Epilepsy, Diagnostics Technology, SUDEP, Wearable Technology, Health Diagnostics

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 6
Investor Investor Investor Investor
•••• ••••
03 Apr 2024
Grant •••••• 1
Investor
28 Sep 2023
Non Equity Assistance •••••• 1
Investor
06 Jun 2023
Seed Round •••••• - 06 Jan 2023
Non Equity Assistance •••••• 1
Investor
28 Jun 2021

Neurava Alternatives & Competitors

Neurava vs

Leading laboratory solutions company in Kazakhstan.

11 employees
Neurava vs
Surfix
Surfix The Netherlands

Redefining Point-of-Care testing

38 employees
Biotechnology
Neurava vs

Rethinking diagnostics in cardiology with quantum sensing & AI

8 employees
Enterprise Software

FAQ About Neurava

Innovative diagnostics technology for managing epilepsy and reducing SUDEP risk.
Neurava was founded in 2019.
Neurava operates in the following industries: Health Care, Medical Devices.
Neurava has approximately 2-10 employees.
Neurava has completed 5 funding rounds, raising a total of $4.23M. The latest funding stage is Seed.
Top alternatives and competitors to Neurava include Zalma Ltd., Surfix, Biomagnetik Park Holding GmbH, TOUCHLABS, Antibody Design. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurava and Zalma Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Neurava and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes